Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development
Abstract Background The recent outbreak by SARS-CoV-2 has generated a chaos in global health and economy and claimed/infected a large number of lives. Closely resembling with SARS CoV, the present strain has manifested exceptionally higher degree of spreadability, virulence and stability possibly du...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02435-4 |
id |
doaj-0a12cc4d30b44924be5c28acd2c7e0f5 |
---|---|
record_format |
Article |
spelling |
doaj-0a12cc4d30b44924be5c28acd2c7e0f52020-11-25T03:52:13ZengBMCJournal of Translational Medicine1479-58762020-07-0118111410.1186/s12967-020-02435-4Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine developmentAmrita Banerjee0Dipannita Santra1Smarajit Maiti2Departmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and TechnologyDepartmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and TechnologyDepartmentof Biochemistry and Biotechnology, Cell and Molecular Therapeutics Laboratory, Oriental Institute of Science and TechnologyAbstract Background The recent outbreak by SARS-CoV-2 has generated a chaos in global health and economy and claimed/infected a large number of lives. Closely resembling with SARS CoV, the present strain has manifested exceptionally higher degree of spreadability, virulence and stability possibly due to some unidentified mutations. The viral spike glycoprotein is very likely to interact with host Angiotensin-Converting Enzyme 2 (ACE2) and transmits its genetic materials and hijacks host machinery with extreme fidelity for self propagation. Few attempts have been made to develop a suitable vaccine or ACE2 blocker or virus-receptor inhibitor within this short period of time. Methods Here, attempt was taken to develop some therapeutic and vaccination strategies with a comparison of spike glycoproteins among SARS-CoV, MERS-CoV and the SARS-CoV-2. We verified their structure quality (SWISS-MODEL, Phyre2, and Pymol) topology (ProFunc), motifs (MEME Suite, GLAM2Scan), gene ontology based conserved domain (InterPro database) and screened several epitopes (SVMTrip) of SARS CoV-2 based on their energetics, IC50 and antigenicity with regard to their possible glycosylation and MHC/paratope binding (Vaxigen v2.0, HawkDock, ZDOCK Server) effects. Results We screened here few pairs of spike protein epitopic regions and selected their energetic, Inhibitory Concentration50 (IC50), MHC II reactivity and found some of those to be very good target for vaccination. A possible role of glycosylation on epitopic region showed profound effects on epitopic recognition. Conclusion The present work might be helpful for the urgent development of a suitable vaccination regimen against SARS CoV-2.http://link.springer.com/article/10.1186/s12967-020-02435-4SARS CoV-2 (COVID 19)Severe global outbreak-Dec 2019Spike glycoproteinACE-2 receptor proteinEpitope designing and screeningVaccination |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amrita Banerjee Dipannita Santra Smarajit Maiti |
spellingShingle |
Amrita Banerjee Dipannita Santra Smarajit Maiti Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development Journal of Translational Medicine SARS CoV-2 (COVID 19) Severe global outbreak-Dec 2019 Spike glycoprotein ACE-2 receptor protein Epitope designing and screening Vaccination |
author_facet |
Amrita Banerjee Dipannita Santra Smarajit Maiti |
author_sort |
Amrita Banerjee |
title |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development |
title_short |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development |
title_full |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development |
title_fullStr |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development |
title_full_unstemmed |
Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development |
title_sort |
energetics and ic50 based epitope screening in sars cov-2 (covid 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2020-07-01 |
description |
Abstract Background The recent outbreak by SARS-CoV-2 has generated a chaos in global health and economy and claimed/infected a large number of lives. Closely resembling with SARS CoV, the present strain has manifested exceptionally higher degree of spreadability, virulence and stability possibly due to some unidentified mutations. The viral spike glycoprotein is very likely to interact with host Angiotensin-Converting Enzyme 2 (ACE2) and transmits its genetic materials and hijacks host machinery with extreme fidelity for self propagation. Few attempts have been made to develop a suitable vaccine or ACE2 blocker or virus-receptor inhibitor within this short period of time. Methods Here, attempt was taken to develop some therapeutic and vaccination strategies with a comparison of spike glycoproteins among SARS-CoV, MERS-CoV and the SARS-CoV-2. We verified their structure quality (SWISS-MODEL, Phyre2, and Pymol) topology (ProFunc), motifs (MEME Suite, GLAM2Scan), gene ontology based conserved domain (InterPro database) and screened several epitopes (SVMTrip) of SARS CoV-2 based on their energetics, IC50 and antigenicity with regard to their possible glycosylation and MHC/paratope binding (Vaxigen v2.0, HawkDock, ZDOCK Server) effects. Results We screened here few pairs of spike protein epitopic regions and selected their energetic, Inhibitory Concentration50 (IC50), MHC II reactivity and found some of those to be very good target for vaccination. A possible role of glycosylation on epitopic region showed profound effects on epitopic recognition. Conclusion The present work might be helpful for the urgent development of a suitable vaccination regimen against SARS CoV-2. |
topic |
SARS CoV-2 (COVID 19) Severe global outbreak-Dec 2019 Spike glycoprotein ACE-2 receptor protein Epitope designing and screening Vaccination |
url |
http://link.springer.com/article/10.1186/s12967-020-02435-4 |
work_keys_str_mv |
AT amritabanerjee energeticsandic50basedepitopescreeninginsarscov2covid19spikeproteinbyimmunoinformaticanalysisimplicatingforasuitablevaccinedevelopment AT dipannitasantra energeticsandic50basedepitopescreeninginsarscov2covid19spikeproteinbyimmunoinformaticanalysisimplicatingforasuitablevaccinedevelopment AT smarajitmaiti energeticsandic50basedepitopescreeninginsarscov2covid19spikeproteinbyimmunoinformaticanalysisimplicatingforasuitablevaccinedevelopment |
_version_ |
1724483688376303616 |